Plieger T, Melchers M, Montag C, Meermann R, Reuter M. Life stress as potential risk factor for depression and burnout. Burn Res. 2015;2:19–24.
WHO, Geneva. WHO methods and data sources for global burden of disease estimates 2000–2011. Department of Health Statistics and Information Systems, 2013.
Andlin-Sobocki P, Jonsson B, Wittchen H-U, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005;12:1–27.
Hirschfeld RMA. The epidemiology of depression and the evolution of treatment. J Clin Psychiatry 2012;73:5–9. https://doi.org/10.4088/JCP.11096su1c.01.
Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162:1171–8. https://doi.org/10.1176/appi.ajp.162.6.1171.
Sher L, Oquendo MA, Galfalvy HC, Grunebaum MF, Burke AK, Zalsman G, et al. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism. Addict Behav. 2005;30:1144–53. https://linkinghub.elsevier.com/retrieve/pii/S0306460304003764.
Sher L, Zalsman G. Alcohol and adolescent suicide. Int J Adolesc Med Health. 2005;17:197–203.
World Health Organisation. WHO suicide Data. 2015. https://www.who.int/mental_health/prevention/suicide/suicideprevent/en/.
Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, Büsselberg D, et al. Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021. EPMA J. 2021;12:243–64. https://doi.org/10.1007/s13167-021-00251-4.
Reddy V, Grogan D, Ahluwalia M, Salles ÉL, Ahluwalia P, Khodadadi H, et al. Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. EPMA J. 2020;11:217–50. https://doi.org/10.1007/s13167-020-00203-4.
Article PubMed PubMed Central Google Scholar
Acker J, Golubnitschaja O, Büttner-Teleaga A, Richter K. Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive and personalised (3P) medicine. EPMA J. 2021;12:349–63. https://doi.org/10.1007/s13167-021-00250-5.
Amare AT, Schubert KO, Baune BT. Pharmacogenomics in the treatment of mood disorders: strategies and opportunities for personalized psychiatry. EPMA J. 2017;8:211–27. https://doi.org/10.1007/s13167-017-0112-8.
Hawton K, van Heeringen K. Suicide. The Lancet 2009;373:1372–81. https://linkinghub.elsevier.com/retrieve/pii/S014067360960372X.
Høyer EH, Olesen AV, Mortensen PB. Suicide risk in patients hospitalised because of an affective disorder: a follow-up study, 1973–1993. J Affect Disord. 2004;78:209–17. http://linkinghub.elsevier.com/retrieve/pii/S0165032702003117.
Braquehais MD, Picouto MD, Casas M, Sher L. Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide. World J Pediatr. 2012;8:197–206. https://doi.org/10.1007/s12519-012-0358-0.
Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4:819–28. http://www.nature.com/articles/nrn1220.
Cavanagh JTO, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33:395–405.
Conwell Y, Duberstein P, Cox C, Herrmann J, Forbes N, Caine E. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry. 1996;153:1001–8. https://doi.org/10.1176/ajp.153.8.1001.
Harwood D, Hawton K, Hope T, Jacoby R. Psychiatric disorder and personality factors associated with suicide in older people: a descriptive and case-control study. Int J Geriatr Psychiatry. 2001;16:155–65.
Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60 Suppl 2:57–62; discussion 75–76, 113–6.
Richter K, Kellner S, Hillemacher T, Golubnitschaja O. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine. EPMA J. 2021;12:221–41. https://doi.org/10.1007/s13167-021-00245-2.
Daly M, Robinson E. Depression and anxiety during COVID-19. Lancet. 2022;399:518. https://linkinghub.elsevier.com/retrieve/pii/S0140673622001878.
Barberis N, Cannavò M, Cuzzocrea F, Verrastro V. Suicidal behaviours during COVID-19 pandemic: a review. Clin Neuropsychiatry. 2022;84. https://doi.org/10.36131/cnfioritieditore20220202.
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester (2006). Making mental health care safer: annual report and 20-year review. University of Manchester. http://www.bbmh.manchester.ac.uk/cmhr/research/centreforsuicideprevention/nci/reports/SuicideinPrimaryCare2006.pdf.
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester (2012). Making mental health care safer: annual report and 20-year review. University of Manchester. University of Manchester. http://www.bbmh.manchester.ac.uk/cmhr/research/centreforsuicideprevention/nci/reports/SuicideinPrimaryCare2012.pdf.
Teismann T, Dorrmann W. Suizidalität. Göttingen Bern Wien: Hogrefe; 2014.
Tsigos C, Kyrou I, Kassi E, Chrousos GP. Stress, endocrine physiology and pathophysiology. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. http://www.ncbi.nlm.nih.gov/books/NBK278995/.
Jiménez-Fernández S, Gurpegui M, Díaz-Atienza F, Pérez-Costillas L, Gerstenberg M, Correll CU. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. J Clin Psychiatry. 2015;76:1658–67. http://www.psychiatrist.com/jcp/article/pages/2015/v76n12/v76n1216.aspx.
Carroll BJ, Cassidy F, Naftolowitz D, Tatham NE, Wilson WH, Iranmanesh A, et al. Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand. 2007;115:90–103.
Vreeburg SA, Hoogendijk WJG, van Pelt J, DeRijk RH, Verhagen JCM, van Dyck R, et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry. 2009;66:617.
Pochigaeva K, Druzhkova T, Yakovlev A, Onufriev M, Grishkina M, Chepelev A, et al. Hair cortisol as a marker of hypothalamic-pituitary-adrenal axis activity in female patients with major depressive disorder. Metab Brain Dis. 2017;32:577–83.
Steudte-Schmiedgen S, Wichmann S, Stalder T, Hilbert K, Muehlhan M, Lueken U, et al. Hair cortisol concentrations and cortisol stress reactivity in generalized anxiety disorder, major depression and their comorbidity. J Psychiatr Res. 2017;84:184–90.
Dienes KA, Hazel NA, Hammen CL. Cortisol secretion in depressed, and at-risk adults. Psychoneuroendocrinology. 2013;38:927–40.
Mayer SE, Lopez-Duran NL, Sen S, Abelson JL. Chronic stress, hair cortisol and depression: a prospective and longitudinal study of medical internship. Psychoneuroendocrinology. 2018;92:57–65.
Rothe N, Steffen J, Penz M, Kirschbaum C, Walther A. Examination of peripheral basal and reactive cortisol levels in major depressive disorder and the burnout syndrome: a systematic review. Neurosci Biobehav Rev. 2020;114:232–70.
Bailey SL, Heitkemper MM. Circadian rhythmicity of cortisol and body temperature: morningness-eveningness effects. Chronobiol Int. 2001;18:249–61.
D’Anna-Hernandez KL, Ross RG, Natvig CL, Laudenslager ML. Hair cortisol levels as a retrospective marker of hypothalamic–pituitary axis activity throughout pregnancy: comparison to salivary cortisol. Physiol Behav. 2011;104:348–53. https://linkinghub.elsevier.com/retrieve/pii/S0031938411001053.
Wennig R. Potential problems with the interpretation of hair analysis results. Forensic Sci Int. 2000;107:5–12. http://linkinghub.elsevier.com/retrieve/pii/S0379073899001462.
Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta. 2006;370:17–49. https://linkinghub.elsevier.com/retrieve/pii/S0009898106001227.
Boumba VA, Ziavrou KS, Vougiouklakis T. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol. 2006;25:143–63.
Villain M, Cirimele V, Kintz P. Hair analysis in toxicology. Clin Chem Lab Med CCLM. 2004;42. https://doi.org/10.1515/CCLM.2004.247.
Stalder T, Tietze A, Steudte S, Alexander N, Dettenborn L, Kirschbaum C. Elevated hair cortisol levels in chronically stressed dementia caregivers. Psychoneuroendocrinology. 2014;47:26–30. https://linkinghub.elsevier.com/retrieve/pii/S0306453014001541.
Dettenborn L, Tietze A, Bruckner F, Kirschbaum C. Higher cortisol content in hair among long-term unemployed individuals compared to controls. Psychoneuroendocrinology. 2010;35:1404–9. https://linkinghub.elsevier.com/retrieve/pii/S030645301000096X.
Steudte S, Kirschbaum C, Gao W, Alexander N, Schönfeld S, Hoyer J, et al. Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol Psychiatry. 2013;74:639–46. https://linkinghub.elsevier.com/retrieve/pii/S0006322313002643.
Koenig AM, Ramo-Fernández L, Boeck C, Umlauft M, Pauly M, Binder EB, et al. Intergenerational gene × environment interaction of FKBP5 and childhood maltreatment on hair steroids. Psychoneuroendocrinology. 2018;92:103–12. https://linkinghub.elsevier.com/retrieve/pii/S0306453017315937.
Dettenborn L, Muhtz C, Skoluda N, Stalder T, Steudte S, Hinkelmann K, et al. Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress. 2012;15:348–53. http://www.tandfonline.com/doi/full/10.3109/10253890.2011.619239.
Gerber M, Kalak N, Elliot C, Holsboer-Trachsler E, Pühse U, Brand S. Both hair cortisol levels and perceived stress predict increased symptoms of depression: an exploratory study in young adults. Neuropsychobiology. 2013;68:100–9. https://www.karger.com/Article/FullText/351735.
Janssens H, Clays E, Fiers T, Verstraete AG, de Bacquer D, Braeckman L. Hair cortisol in relation to job stress and depressive symptoms. Occup Med. 2017;67:114–20.
Staufenbiel SM, Penninx BWJH, Spijker AT, Elzinga BM, van Rossum EFC. Hair cortisol, stress exposure, and mental health in humans: a systematic review. Psychoneuroendocrinology. 2013;38:1220–35. https://linkinghub.elsevier.com/retrieve/pii/S0306453012004027.
Wei J, Sun G, Zhao L, Yang X, Liu X, Lin D, et al. Analysis of hair cortisol level in first-episodic and recurrent female patients with depression compared to healthy controls. J Affect Disord. 2015;175:299–302.
Psarraki EE, Kokka I, Bacopoulou F, Chrousos GP, Artemiadis A, Darviri C. Is there a relation between major depression and hair cortisol? A systematic review and meta-analysis. Psychoneuroendocrinology. 2021;124:105098. https://linkinghub.elsevier.com/retrieve/pii/S0306453020305217.
Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 1995;28:45–50. https://doi.org/10.1055/s-2007-979587.
Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry. 2001;158:748–53. https://doi.org/10.1176/appi.ajp.158.5.748.
Jokinen J, Nordström P. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology. 2008;33:1387–93. https://linkinghub.elsevier.com/retrieve/pii/S0306453008001911.
O’Connor DB, Green JA, Ferguson E, O’Carroll RE, O’Connor RC. Cortisol reactivity and suicidal behavior: investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators. Psychoneuroendocrinology. 2017;75:183–91. https://linkinghub.elsevier.com/retrieve/pii/S0306453016308435.
Pérez-Ortiz JM, García-Gutiérrez MS, Navarrete F, Giner S, Manzanares J. Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology. 2013;38:1251–8. https://linkinghub.elsevier.com/retrieve/pii/S0306453012003770.
Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA. Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology. 2013;38:616–27. http://www.nature.com/articles/npp2012225.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fourth Edition, Text Revision (DSM-IV-TR). 4th ed. Arlington, VA: American Psychiatric Association; 2000. https://doi.org/10.1176/ajp.152.8.1228.
Karabatsiakis A, Böck C, Salinas-Manrique J, Kolassa S, Calzia E, Dietrich DE, et al. Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry. 2014;4:e397–e397. http://www.nature.com/articles/tp201444.
Boeck C, Salinas-Manrique J, Calzia E, Radermacher P, von Arnim CAF, Dietrich DE, et al. Targeting the association between telomere length and immuno-cellular bioenergetics in female patients with major depressive disorder. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-26867-7.
Boeck C, Pfister S, Bürkle A, Vanhooren V, Libert C, Salinas-Manrique J, et al. Alterations of the serum N-glycan profile in female patients with major depressive disorder. J Affect Disord. 2018;234:139–47.
Hautzinger M, Keller F, Kühner C. Beck depressions inventar revision—manual. Frankfurt, Germany: Harcourt Test Services. 2006.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci. 1979;134:382–9.
Davenport MD, Tiefenbacher S, Lutz CK, Novak MA, Meyer JS. Analysis of endogenous cortisol concentrations in the hair of rhesus macaques. Gen Comp Endocrinol. 2006;147:255–61. https://linkinghub.elsevier.com/retrieve/pii/S0016648006000190.
Dettenborn L, Kirschbaum C, Gao W, Spitzer C, Roepke S, Otte C, et al. Increased hair testosterone but unaltered hair cortisol in female patients with borderline personality disorder. Psychoneuroendocrinology. 2016;71:176–9. https://linkinghub.elsevier.com/retrieve/pii/S0306453016301615.
Miret M, Ayuso-Mateos JL, Sanchez-Moreno J, Vieta E. Depressive disorders and suicide: epidemiology, risk factors, and burden. Neurosci Biobehav Rev. 2013;37:2372–4. https://linkinghub.elsevier.com/retrieve/pii/S0149763413000092.
Barraclough B, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry J Ment Sci. 1974;125:355–73.
Pirkis J, Burgess P. Suicide and recency of health care contacts. A systematic review. Br J Psychiatry J Ment Sci. 1998;173:462–74.
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol . 2016;16:22–34. http://www.nature.com/articles/nri.2015.5.
Karabatsiakis A, Kolassa I-T, Kolassa S, Rudolph KL, Dietrich DE. Telomere shortening in leukocyte subpopulations in depression. BMC Psychiatry. 2014;14. Available from: https://doi.org/10.1186/1471-244X-14-192.
Wang X, Sundquist K, Rastkhani H, Palmér K, Memon AA, Sundquist J. Association of mitochondrial DNA in peripheral blood with depression, anxiety and stress- and adjustment disorders in primary health care patients. Eur Neuropsychopharmacol. 2017;27:751–8. https://linkinghub.elsevier.com/retrieve/pii/S0924977X1730278X.
Lindqvist D, Fernström J, Grudet C, Ljunggren L, Träskman-Bendz L, Ohlsson L, et al. Increased plasma levels of circulating cell-free mitochondrial DNA in suicide attempters: associations with HPA-axis hyperactivity. Transl Psychiatry. 2016;6:e971–e971. http://www.nature.com/articles/tp2016236.
Conrad CD. Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci. 2008;19:395–411.
Gehring WJ, Goss B, Coles MGH, Meyer DE, Donchin E. A neural system for error detection and compensation. Psychol Sci. 1993;4:385–90. https://doi.org/10.1111/j.1467-9280.1993.tb00586.x.
Dettenborn L, Tietze A, Kirschbaum C, Stalder T. The assessment of cortisol in human hair: associations with sociodemographic variables and potential confounders. Stress. 2012;15:578–88. https://doi.org/10.3109/10253890.2012.654479.
Phillips R, Kraeuter A-K, McDermott B, Lupien S, Sarnyai Z. Human nail cortisol as a retrospective biomarker of chronic stress: a systematic review. Psychoneuroendocrinology. 2021;123:104903.
Herane-Vives A, Ortega L, Sandoval R, Young AH, Cleare A, Espinoza S, et al. Measuring earwax cortisol concentration using a non-stressful sampling method. Heliyon. 2020;6:e05124.
Hawton K, Casañas i Comabella C, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord [Internet]. 2013;147:17–28. https://linkinghub.elsevier.com/retrieve/pii/S0165032713000360.
Kino T. Glucocorticoid Receptor. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. http://www.ncbi.nlm.nih.gov/books/NBK279171/.
留言 (0)